Corvus Pharmaceuticals CRVS Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.23B.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's market capitalization?
- Corvus Pharmaceuticals (CRVS) reported market capitalization of $1.23B in Q1 2026.
- How has Corvus Pharmaceuticals's market capitalization changed year-over-year?
- Corvus Pharmaceuticals's market capitalization increased by 467.1% year-over-year, from $216.67M to $1.23B.
- What is the long-term trend for Corvus Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's market capitalization has grown at a 28.3% compound annual growth rate (CAGR), from $165.71M to $575.05M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.